CMS to Increase Scrutiny of Psychotropic Drug Use
Posted on December 22, 2022 by LeadingAge
The Office of the Inspector General (OIG) released a report outlining the potentially inappropriate use of several psychotropic medications, including antipsychotics, anxiolytics, sedative-hypnotics, and anticonvulsants. As a result, the Centers for Medicare and Medicaid Services (CMS) plans to increase its oversight of psychotropic drugs and focus more closely on certain drug classes.
CMS to Increase Scrutiny of Psychotropic Drug Use
Members Only
The resource you are trying to access is a Members Only Resource. If you are a member of LeadingAge Minnesota, simply log in. If you forgot your password or aren't sure if you have an account, use the "Forgot your password?" link on the Log In page.
Want to become a member? Click here for further information.
Comments
Add a comment
Members must sign in to comment
You must be a member to comment on this article. If you are already a member, please log in. Not a member? Learn how to join »
No one has commented on this article yet. Please post a comment below.